David P. Snow's Net Worth

-$394 Thousand

Estimate Recalculated Feb 7, 2024 03:53PM EST

Who is David P. Snow?

David P. Snow does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Radius Health, Inc., and Eloxx Pharmaceuticals, Inc..

SEC CIK

David P. Snow's CIK is 0001652972

Past Insider Trading and Trends

2020 was David P. Snow's most active year for acquiring shares with 4 total transactions. David P. Snow's most active month to acquire stocks was the month of December. 2020 was David P. Snow's most active year for disposing of shares, totalling 5 transactions. David P. Snow's most active month to dispose stocks was the month of December. 2015 saw David P. Snow paying a total of $418,740.00 for 131,000 shares, this is the most they've acquired in one year. In 2020 David P. Snow cashed out on 16,562 shares for a total of $20,793.32, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Radius Health, Inc. No price found

Chief Commercial Officer

David P. Snow owns 6,000 units of Common Stock. From 2015 to 2017 David P. Snow acquired a total of 6,000 shares in Radius Health, Inc. at a cost of $418,740.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 17
Form 4
—
0
—
—
0
Feb 10
Form 4
∞
6K
$69.79
$418,740.00
6K
Sep 14
Form 4
—
0
—
—
0
Sep 9
Form 3
—
0
—
—
0
No matching records found

Eloxx Pharmaceuticals, Inc. (ELOX) Snapshot price: $0.82125

CHIEF BUSINESS OFFICER

David P. Snow owns 4,205 units of Common Stock which is worth $3,453.36. From 2018 to 2020 David P. Snow acquired a total of 17,188 shares in Eloxx Pharmaceuticals, Inc., David also disposed a total of 5,624 shares of Eloxx Pharmaceuticals, Inc. equalling to $20,793.32.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
∞
4.21K
$3.91
-$7,995.95
4.21K
Jan 30
Form 4
+75.01%
3.15K
$3.13
-$4,801.42
7.36K
Feb 29
Form 4
∞
4.21K
$3.91
-$7,995.95
4.21K
Jan 30
Form 4
—
0
—
—
0
Sep 12
Form 4
—
0
—
—
0
Jan 30
Form 4
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found